Immune to Cancer: The CRI Blog
-
CRI Fellow Dr. Kamir Hiam-Galvez Shares a Day in His Life on CRI’s Twitter
Get to know Dr. Kamir Hiam-Galvez: immunologist, coffee drinker, music lover, and CRI Irvington Postdoctoral Fellow at…
-
Acute Lymphoblastic Leukemia Survivor Kristin Kleinhofer Takes Over CRI’s Instagram
Patient advocate and leukemia survivor Kristin shares a day in her life on Instagram.
-
ASCO21 Recap: Immunotherapy’s Continued Progress and Addressing Healthcare Disparities
ASCO21 highlighted the latest immunotherapy advances in checkpoint inhibition and cell therapies, and addressed disparities in healthcare.
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
Impacto de la pandemia de COVID-19 en los ensayos clínicos oncológicos: análisis de seguimiento a un año
Un nuevo informe del CRI destaca la repercusión de la pandemia de COVID-19 en los ensayos clínicos…
-
12 Challenges for 2021: Fundraising Ideas for Every Month of the Year
Commit to change in 2021 and advance cancer immunotherapy research. Get fundraising ideas for every month of…
-
Skin Cancer Awareness Month: 2021 Immunotherapy Research Updates
This May for Skin Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Brain Tumor Awareness Month: 2021 Immunotherapy Research Updates
This May for Brain Tumor Awareness Month, we look at new research, new treatments, and how we’re…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.